Source: Annual Congress 2006 - Cardiovascular pathophysiology
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. V. Yahorava, D. G. Lasyuk, H. L. Hurevich, I. M. Lapteva (Minsk, Belarus). Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 2380

Member's Comments

No comment yet.

Related content which might interest you: Secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD? Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 The diagnosis of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension? Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020 Year: 2020 Diagnosis of pulmonary hypertension Source: Eur Respir J, 53 (1) 1801904; 10.1183/13993003.01904-2018 Year: 2019 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017 Sildenafil for treatment of associated pulmonary hypertension in patients with severe COVID-19 pneumonia. Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020 Year: 2020 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013